First Time Loading...

Immuno-Biological Laboratories Co Ltd
TSE:4570

Watchlist Manager
Immuno-Biological Laboratories Co Ltd Logo
Immuno-Biological Laboratories Co Ltd
TSE:4570
Watchlist
Price: 460 JPY -0.43% Market Closed
Updated: May 3, 2024

Immuno-Biological Laboratories Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immuno-Biological Laboratories Co Ltd
Operating Income Peer Comparison

Comparables:
2309
2370
4880
2183
7079

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Immuno-Biological Laboratories Co Ltd
TSE:4570
Operating Income
¥50.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CMIC Holdings Co Ltd
TSE:2309
Operating Income
¥5.5B
CAGR 3-Years
30%
CAGR 5-Years
5%
CAGR 10-Years
4%
Medinet Co Ltd
TSE:2370
Operating Income
-¥1.4B
CAGR 3-Years
-10%
CAGR 5-Years
1%
CAGR 10-Years
-4%
CellSource Co Ltd
TSE:4880
Operating Income
¥1.2B
CAGR 3-Years
43%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Linical Co Ltd
TSE:2183
Operating Income
¥1.2B
CAGR 3-Years
50%
CAGR 5-Years
-5%
CAGR 10-Years
4%
WDB coco Co Ltd
TSE:7079
Operating Income
¥1.1B
CAGR 3-Years
32%
CAGR 5-Years
30%
CAGR 10-Years
N/A

See Also

What is Immuno-Biological Laboratories Co Ltd's Operating Income?
Operating Income
50.2m JPY

Based on the financial report for Dec 31, 2023, Immuno-Biological Laboratories Co Ltd's Operating Income amounts to 50.2m JPY.

What is Immuno-Biological Laboratories Co Ltd's Operating Income growth rate?
Operating Income CAGR 1Y
51%

Over the last year, the Operating Income growth was 51%.